News
Relmada Therapeutics
RLMD · NASDAQ
$3.36+$0.20 (+6.33%)TodayMarket closed ·
Prev close $3.16
Latest news
- Press releaseGlobe Newswire
Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
- Press releaseGlobe Newswire
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
- NewsVandana Singh
Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call
- Press releaseGlobe Newswire
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
- NewsAvi Kapoor
Hewlett Packard Enterprise Posts Blowout Q2 Earnings, Joins Marvell Technology And Other Big Stocks Moving Higher In Tuesday's Session
- News
Transcript: Relmada Therapeutics Q1 2026 Earnings Conference Call
- Press releaseGlobe Newswire
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
- News
Earnings Scheduled For May 12, 2026
- Press releaseGlobe Newswire
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
- Press releaseGlobe Newswire
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
- News
Earnings Scheduled For March 19, 2026
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
Market-Moving News for March 9th
- Press releaseGlobe Newswire
Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer
- Press releasePRNewswire
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders
- Press releaseGlobe Newswire
Relmada Therapeutics Reports Third Quarter 2025 Financial Results and Provides Key Clinical, Regulatory, and Corporate Updates
- News
Earnings Scheduled For November 13, 2025
- News
A Glimpse of Relmada Therapeutics's Earnings Potential
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- NewsAvi Kapoor
Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Nasdaq Surges 150 Points; ISM Services PMI Falls In November
- NewsAvi Kapoor
Dow Gains 250 Points; Salesforce Shares Jump After Q3 Results
- Press releasePRNewswire
Relmada Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
- News
A Look Ahead: Relmada Therapeutics's Earnings Forecast
- Press releasePRNewswire
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm
- Press releasePRNewswire
Relmada Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- Press releasePRNewswire
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.